Online edition of India's National Newspaper
Wednesday, Oct 24, 2007
ePaper
Online edition of India's National Newspaper Wednesday, Oct 24, 2007 ePaper |
|
|
|
|
|
|
| Tamil Nadu |
|
News:
ePaper |
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
Advts: Retail Plus | Classifieds | Jobs | Obituary |
Tamil Nadu
R. Avudaiappan CHENNAI: Legislators must take the message of HIV prevention and status of vaccine trial to the people, Assembly Speaker R. Avudaiappan said on Monday. Addressing a meeting of people’s representatives on the role of preventive technologies in HIV/AIDS organised here by the International AIDS Vaccine Initiative, Mr. Avudaiappan urged his colleagues in the audience to ensure that the relevant messages reached the people. He also stressed on the need to hasten the process of finding a vaccine and cure for HIV. Earlier, professionals involved in the second AIDS vaccine project in India at the Tuberculosis Research Centre, Chennai, made a presentation on the progress of the AIDS vaccine trial. P.R.Narayanan, Director, TRC, said no disease could be eliminated without the aid of a vaccine. The trial was being conducted in a transparent and ethical manner involving volunteers of a cross section of society and with constant monitoring. V.R. Ramanathan, deputy director, TRC, said 367 people responded to the communication strategy adopted in the pre-launch stage. Of them, 67 expressed their willingness to participate in the trial and 32 of them were chosen after tests to participate in the HIV vaccine trial. They came from all segments of society. He said the first phase of the trial had established the safety of the vaccine being tested — no volunteer exhibited any side effects. Each volunteer was paid Rs.500 a visit and would have to make repeated visits over the trial period of 1.5 years. Insurance was also being provided for a period of two years for non-trial related events. Congress MLA Peter Alphonse said the insurance cover should be extended for a longer period — at least five years — and the responsibility of taking care of the volunteers after the trial stage should be considered by both IAVI and the Government, he added. Representative of the Indian Network of Positive Persons, Senthil, articulated the needs of the positive community who had been forced to move to second line drugs. The cost of diagnostics to move to second line drugs itself was very expensive, not to mention the price of drugs. He added that the emphasis on finding a preventive vaccine should be matched by a similar effort to find a therapeutic vaccine. MLA Ghayathri Devi and IAVI representatives Sweta Das and Ashok Malik spoke.
Printer friendly
page
News:
ePaper |
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
|
|
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | Publications | eBooks | Images | Home |
Copyright © 2007, The
Hindu. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu
|
